Keyphrases
Type 2 Diabetic Patients
100%
Four-level
100%
Pioglitazone
100%
Lipoxin A4 (LXA4)
100%
Hemoglobin A1c (HbA1c)
50%
Type 2 Diabetes Mellitus (T2DM)
33%
Serum Adiponectin
33%
Homeostasis Model Assessment of Insulin Resistance (HOMA-IR)
33%
Adiponectin
33%
Dose Escalation
33%
Inflammation
16%
Eicosanoids
16%
Inflammation Resolution
16%
Free Fatty Acids
16%
Arachidonic Acid
16%
Thiazolidinediones
16%
Fasting Plasma Glucose
16%
Plasma Free Fatty Acids
16%
T2DM Patients
16%
Changes in Body Weight
16%
Lipoxin
16%
Lipid Mediators
16%
Pharmacology, Toxicology and Pharmaceutical Science
Pioglitazone
100%
Lipoxin A
100%
Non Insulin Dependent Diabetes Mellitus
100%
Adiponectin
66%
Hemoglobin A1c
50%
Fatty Acid
33%
Inflammation
33%
Anti-Inflammatory Drug
16%
Thiazolidinedione
16%
Icosanoid
16%
Arachidonic Acid
16%
Lipoxin
16%